Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

Test Box office collection - Check out Test Day wise box office collection, Weekend box office collection, total Worldwide box office collection till now. Know how much first day collection of ...